Cardio-metabolic features of type 2 diabetes subjects discordant in the diagnosis of metabolic syndrome

Diabetes and Metabolism Journal

Volumn 36, Issue 5, 2012, Pages 357-363

  Lee, Sa Rah ^a   Han, Ying ^b   Kim, Ja Won ^c   Park, Ja Young ^d   Kim, Ji Min ^e   Suh, Sunghwan ^f   Park, Mi kyoung ^g   Lee, Hye jeong ^h   Kim, Duk Kyu ^g  

^a Division of Endocrinology and Metabolism   (South Korea)

^b Dong A University   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d Busan St Mary's Medical Center   (South Korea)

^e Hanseo Hospital   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g Pusan National University   (South Korea)

^h Dong A University College of Medicine   (South Korea)

Author keywords

Diabetes mellitus; Discordant group; Metabolic syndrome; Waist circumference

Indexed keywords

EID: 84870268285     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2012.36.5.357     Document Type: Article

References (24)

1. Hanley AJ, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P, Tracy RP, Saad MF, Haffner S; Insulin Resistance Atherosclerosis Study. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642-7.
2. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
3. Metascreen Writing Committee, Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006;29:2701-7.
4. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006;49:49-55.
5. Chung HS, Seo JA, Kim SG, Kim NH, Kim DM, Chung CH, Choi DS. Relationship between metabolic syndrome and risk of chronic complications in Koreans with type 2 diabetes. Korean Diabetes J 2009;33:392-400.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
7. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B; European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-76.
8. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62.
9. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7.
10. Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P, Hoefle G, Drexel H. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006;29:901-7.
11. Lee DY, Rhee EJ, Choi ES, Kim JH, Won JC, Park CY, Lee WY, Oh KW, Park SW, Kim SW. Comparison of the predictability of cardiovascular disease risk according to different metabolic syndrome criteria of American Heart Association/National Heart, Lung, and Blood Institute and International Diabetes Federation in Korean men. Korean Diabetes J 2008;32:317-27.
12. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007;99:541-8.
13. Bassett J; International Diabetes Institute; World Health Organization Regional Office for the Western Pacific; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
14. Choi SH, Kim DJ, Lee KE, Kim YM, Song YD, Kim HD, Ahn CW, Cha BS, Huh KB, Lee HC. Cut-off value of waist circumference for metabolic syndrome patients in Korean adult population. J Korean Soc Study Obes 2004;13:53-60.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
16. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised nationa cholesterol education program: the Korea NHANES study. Int J Obes (Lond) 2007;31:528-34.
17. Iwasaki T, Togashi Y, Ohshige K, Yoneda M, Fujita K, Nakajima A, Terauchi Y. Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2008;79:427-32.
18. Kim TH, Kim DJ, Lim S, Jeong IK, Son HS, Chung CH, Koh G, Lee DH, Won KC, Park JH, Park TS, Ahn J, Kim J, Park KG, Ko SH, Ahn YB, Lee I. Prevalence of the metabolic syndrome in type 2 diabetic patients. Korean Diabetes J 2009;33:40-7.
19. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
20. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999;18:353-8.
21. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
22. Kim JM, Park JY, Nam HK, Kim JW, Park SK, Nam KJ, Park MK, Lee HJ, Kim DK. Prevalence of metabolic syndrome in type 2 DM patients with non-alcoholic fatty liver. J Korean Diabetes Assoc 2006;30:442-9.
23. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.
24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.